Table 1.
Group A1 | Group B2 | Groups A + B | Group C (Controls) | |
---|---|---|---|---|
Total number | 41 | 62 | 103 | 55 |
Females, n (%) | 39 (95.1%) | 56 (88.7%) | 94 (91.3%) | 53 (96.4%) |
Age in years, mean (SD) | 42.3 (11.9) | 40.87 (11.3) | 41.3 (11.5) | 40.8 (12.1) |
Race, n (%) | ||||
Caucasian | 25 (61.0%) | 37 (59.7%) | 62 (60.2%) | 43 (78.2%) |
African | 11 (26.8%) | 12 (19.4%) | 23 (22.3%) | 10 (18.2%) |
Native American | 4 (9.8%) | 10 (16.1%) | 14 (13.6%) | 1 (1.8%) |
Asian | 1 (2.4%) | 3 (4.8%) | 4 (3.9%) | 1 (1.8%) |
SLE patients participating in cross-sectional and prospective substudy.
SLE patients participating in cross-sectional substudy only.